A PROMISING NEW DEVICE FOR DIABETICS
The Pfizer company and Inhale Therapeutic Systems announced that they are collaborating on a device that will allow diabetes patients to inhale insulin rather than inject the drug. Of the more than 14 million Americans who have diabetes, some 500,000 must take insulin every day. Inhale said it has completed the first phase of clinical trials on the product and that Pfizer expects to start trials on people later this year.
Most Popular »
- How Cash Keeps Poor People Poor
- E.T. Turns 30: 10 Things You Didn't Know About Our Favorite Extraterrestrial
- 15-Year-Old Creates Test for Pancreatic Cancer
- Fourth Flesh-Eating-Bacteria Case Confirmed in Georgia, Possible Fifth
- Nevada Ghosts: Rare Photos From an A-Bomb Test
- A New First Amendment Right: Videotaping The Police
- No Spontanaeity Allowed: How to Visit North Korea as a Tourist in Four (Restrictive) Steps
- Euro Crisis: Why A Greek Exit Could Be Much Worse Than Expected
- 10 Dangerous Products You Might Have in Your Home
- Could a Fertility Gene Discovery Lead to New Male Contraception?
- Researchers Probe the Potential Health Benefits of Palm Oil
- A Visit with Turkey's Controversial Religious Movement
- Feeding the Planet Without Destroying It
- Bubble on the Potomac
- Falcon's Liftoff: How a Private Firm Could Change Space Exploration
- The Fatal Flight of the Superjet 100: Why Did It Slam Into a Mountain?
- Learning That Works
- The Man Who Remade Motherhood
- Bibi's Choice
- Seoul: 10 Things to Do




